News | January 14, 2023
Global (68M) cardiomyopathies market set to reach $9.63 bn by 2031: GlobalData
The cardiomyopathies market in the 68M is set to grow at a CAGR of 12.1%
The cardiomyopathies market in the 68M is set to grow at a CAGR of 12.1%
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
The implementing agency of PMBJP has invited online applications for opening of new Jan Aushadhi Kendras in 651 districts of different States/UTs
The company has played an important role in the procurement and distribution of emergency medical supplies supporting the Union Health Ministry for Covid–19 pandemic management
Palbociclib has a unique mechanism of action which helps in delaying disease progression when co-administered with hormonal therapies
The JUST 100 is the only ranking that recognizes companies doing right by all their stakeholders as defined by the American public.
The new project further expands the partner's long-term collaboration on new technologies for R&D
Zydus is the first company to receive final approval and launch Topiramate Extended-Release Capsules, USP 25 mg, 50 mg, and 100 mg in the United States.
Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg, have an estimated market size of US$ 177 million for twelve months ending Sep 2022
Subscribe To Our Newsletter & Stay Updated
